[Results of 30 days and 12 months treatment with salmeterol in patients with asthma and COPD]. / Wyniki 30-dniowego i 12-miesiecznego leczenia salmeterolem chorych na astme i przewlekla obturacyjna chorobe pluc.

ABSTRACT

148 outpatients with asthma and COPD were treated with inhaled steroids and salmeterol. 48 patients were estimated after 30 days treatment and other 100, who accepted salmeterol after 1 year treating. In these two groups of patients inhalations of other beta-mimethics, dyspnoe during the nights and early mornings, change of FEV1, side effects and acceptation of salmeterol were observed. After 1 months of treatment in 45% and after 1 year in 73% increase of FEV1 were noticed. In asthma group in 66% and in 15% COPD patients increase of MEV50 was observed. After 30 days 22% asthma patients and 30% COPD patients did not accept salmeterol. 6 persons had adverse effects/tachycardia, sore throat, exacerbation of dyspnoe/. After 12 months 87% accepted treatment with salmeterol. In 13 cases therapy with salmeterol was stopped, because results were poor.